Impact of Height Exponents on the Diagnosis and Prognosis of LVH: The REMODEL Study

Clement Lee1, Ryan Chan2, Desiree-Faye Toh3

  • 1University of Dundee, Dundee, Scotland.

JACC. Asia
|March 6, 2025
PubMed

Insights

New height exponents for left ventricular hypertrophy (LVH) improve LV mass normalization but do not enhance cardiovascular event prediction. Sex-specific exponents are crucial for accurate LVH diagnosis in diverse populations.

Area of Science:

  • Cardiovascular Imaging and Diagnostics
  • Cardiac Remodeling and Hypertrophy
  • Predictive Analytics in Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant predictor of adverse cardiovascular outcomes.
  • Current methods for normalizing left ventricular mass (LVM) to body size using height exponents lack standardized recommendations.
  • A scarcity of normal reference cohorts hinders the definition of appropriate height exponents for LVH assessment.

Purpose of the Study:

  • To establish sex- and ethnicity-specific height exponents for left ventricular mass (LVM) normalization.
  • To evaluate the diagnostic and prognostic implications of these novel height exponents in cardiovascular magnetic resonance imaging (CMR).
  • To assess the impact of sex-specific height exponents on LVH reclassification and event prediction in hypertensive patients.

Main Methods:

  • Established height exponents using a cohort of 416 healthy, nonoverweight/nonobese Asian volunteers.
  • Assessed the impact of these exponents in a separate cohort of 878 Asian hypertensive subjects using CMR.
  • Defined the primary outcome as a composite of acute coronary syndrome, heart failure hospitalization, stroke, and cardiovascular mortality.

Main Results:

  • Derived sex-specific height exponents: 1.57 for females and 2.33 for males.
  • Utilizing sex-specific height exponents increased LVH prevalence from 27% to 47% in hypertensive patients, primarily reclassifying overweight/obese individuals.
  • Both indexing methods (height exponent and body surface area) independently associated LVH with increased adverse events, with no significant difference in predictive accuracy.

Conclusions:

  • Reference ranges for height exponents should be specific to ethnicity, sex, and imaging modality for accurate LVH assessment.
  • While height exponents led to significant LVH reclassification, they did not improve the prediction of cardiovascular events.
  • Further research is needed to refine LVH normalization techniques and their prognostic value.
Abstract